Shareck J and Belhumeur P |
Modulation of morphogenesis in Candida albicans by various small molecules. |
2011 |
Eukaryotic Cell |
pmid:21642508
|
Barkan B et al. |
Phenotypic reversion of invasive neurofibromin-deficient schwannoma by FTS: Ras inhibition reduces BMP4/Erk/Smad signaling. |
2011 |
Mol. Cancer Ther. |
pmid:21632464
|
Yoo S et al. |
Antimicrobial traits of tea- and cranberry-derived polyphenols against Streptococcus mutans. |
2011 |
Caries Res. |
pmid:21720161
|
Mor A et al. |
Inhibitory effect of farnesylthiosalicylic acid on mediators release by mast cells: preferential inhibition of prostaglandin D(2) and tumor necrosis factor-α release. |
2011 |
Inflammation |
pmid:20706780
|
Navarro-Moll MC et al. |
In vitro and in vivo activity of three sesquiterpenes against L(3) larvae of Anisakis type I. |
2011 |
Exp. Parasitol. |
pmid:20932829
|
Hall RA et al. |
The quorum-sensing molecules farnesol/homoserine lactone and dodecanol operate via distinct modes of action in Candida albicans. |
2011 |
Eukaryotic Cell |
pmid:21666074
|
Kraitzer A et al. |
Composite fiber structures with antiproliferative agents exhibit advantageous drug delivery and cell growth inhibition in vitro. |
2011 |
J Pharm Sci |
pmid:20623695
|
Fitzpatrick AH et al. |
Roles for farnesol and ABA in Arabidopsis flower development. |
2011 |
Plant Signal Behav |
pmid:21758018
|
Mor A et al. |
Ras inhibition induces insulin sensitivity and glucose uptake. |
2011 |
PLoS ONE |
pmid:21738773
|
Sharma M and Prasad R |
The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21768514
|
Riely GJ et al. |
A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations. |
2011 |
J Thorac Oncol |
pmid:21847063
|
Mor A et al. |
Inhibition of contact sensitivity by farnesylthiosalicylic acid-amide, a potential Rap1 inhibitor. |
2011 |
J. Invest. Dermatol. |
pmid:21716322
|
Pando R et al. |
The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat. |
2010 Mar-Apr |
Cardiovasc. Pathol. |
pmid:19144546
|
Wang C et al. |
Farnesol production from Escherichia coli by harnessing the exogenous mevalonate pathway. |
2010 |
Biotechnol. Bioeng. |
pmid:20552672
|
Joo JH and Jetten AM |
Molecular mechanisms involved in farnesol-induced apoptosis. |
2010 |
Cancer Lett. |
pmid:19520495
|
Ling Y et al. |
Synthesis and evaluation of nitric oxide-releasing derivatives of farnesylthiosalicylic acid as anti-tumor agents. |
2010 |
Bioorg. Med. Chem. |
pmid:20435479
|
Sarazin A et al. |
In vitro pro- and anti-inflammatory responses to viable Candida albicans yeasts by a murine macrophage cell line. |
2010 |
Med. Mycol. |
pmid:20438293
|
Gregus P et al. |
Ultra high performance liquid chromatography tandem mass spectrometry analysis of quorum-sensing molecules of Candida albicans. |
2010 |
J Pharm Biomed Anal |
pmid:20580513
|
Bustinza-Linares E et al. |
Salirasib in the treatment of pancreatic cancer. |
2010 |
Future Oncol |
pmid:20528225
|
Endo S et al. |
Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10. |
2010 |
Bioorg. Med. Chem. |
pmid:20304656
|